UTMD Reports Audited Year 2021 and Fourth Quarter Financial Performance
Salt Lake City, Utah, Feb. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- The fourth calendar quarter (4Q) of 2021...
Day: February 1, 2022
Clover Appoints Nicholas Jackson, Ph.D., as President of Global Research and Development
CHENGDU, China, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing...
ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer
Urvashi Tyagi, ResMed Chief Technology Officer Urvashi Tyagi, ResMed Chief Technology Officer Tyagi brings over 25 years’ IT and leadership...
Former Walmart Executive Marcus Osborne Joins Icario’s Medicaid Advisory Council
Healthcare Veteran Brings His Unique Experience Engaging With Hard-to-Reach PopulationsMINNEAPOLIS, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Icario, the healthcare industry’s...
Denali Therapeutics Announces Presentations on DNL310 (ETV:IDS) Development Program in MPS II (Hunter Syndrome) at the Upcoming WORLDSymposium™
SOUTH SAN FRANCISCO, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a...
Shineco, Inc. Appoints Professor Qiyin Sun as Chief Medical Consultant
BEIJING, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of...
Sorrento Completes Acquisition of Virex Health, Will Commercialize Next-Generation at-Home Diagnostic Testing That Rivals PCR-Level Sensitivity for Daily Covid-19 Tests and Early Cancer Diagnosis
Virex Health, Inc. is a Boston, Massachusetts company that has developed a powerful, broadly applicable at-home diagnostic platform (“Virex Technology”).Virex...
Biofrontera Inc. provides Update on Patient Recruitment for Phase III Study for the Treatment of sBCC with Ameluz®-PDT
WOBURN, Mass., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the...
Cannabix Technologies Develops Version 4.0 of THC Breath Analyzer Device
Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safety Cannabix Technologies...
Quotient Limited Provides MosaiQ Regulatory & Commercial Update
The company remains in contact with the European Notified Body and continues to anticipate approval in Q1 CY22First time attendance...
Acer Therapeutics to Participate in 2022 BIO CEO & Investor Conference
NEWTON, Mass., Feb. 01, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition,...
Liver Institute Northwest Participating in RESPONSE, a Global Phase 3 Clinical Research Study Evaluating an Investigational Therapy for the Treatment of Primary Biliary Cholangitis (PBC)
Novel oral medication could provide a new treatment option for people with PBC who have not achieved the recommended treatment...
POINT Biopharma Provides Update on Manufacturing, Supply Chain and Late-Stage Programs
Company’s radiopharmaceutical manufacturing facility now operational, supplying doses for the Phase 3 SPLASH trial – view the facility at manufacturing.pointbiopharma.com...
SELLAS Life Sciences Announces Completion of Enrollment of Phase 1/2 Clinical Trial of GPS in Combination with Pembrolizumab in Advanced Metastatic Ovarian Cancer
Joint Development Committee of SELLAS and Merck Agreed on Study Completion and Overall Operational Path Towards Data Analysis Interim Data...
Veru Enters into Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company to Evaluate Enobosarm in Combination with Verzenio® in Phase 3 ENABLAR-2 Trial
-- Phase 3 ENABLAR-2 Clinical Trial for 2nd Line Treatment of AR+ER+HER2- Metastatic Breast Cancer Expected to Commence During First Quarter...
Skye Bioscience Reports Potential Neuroprotective Benefit of SBI-100 In Preclinical Glaucoma Model
SAN DIEGO, CA, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical...
SmileDirectClub to Report Fourth Quarter and Year End 2021 Results on February 28, 2022
NASHVILLE, Tenn., Feb. 01, 2022 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (Nasdaq: SDC), the next generation oral care company with the...
Inkblot Technologies Appoints Denise Richardson as SVP, Commercial
Toronto, Ontario--(Newsfile Corp. - February 1, 2022) - Inkblot Technologies (Inkblot), Canada's fastest growing virtual mental health provider, is excited...
Halberd Achieves Landmark Selective Elimination of Tau From an Antigen Mixture
Tau has been shown to be important in the development of Alzheimer's Disease.Eradication of tau accomplished without reducing levels of...
Psyched Wellness Announces Launch of New Logo, Branding, and Website, Prepares to Release Industry-First Amanita Muscaria Tincture
Toronto, Ontario--(Newsfile Corp. - February 1, 2022) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
